The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good safety profile.| ALS News Today
The scientists believe the algorithm they developed could be used to help patients and doctors make better treatment and care plans.| ALS News Today
Steve Bryson is a science writer for ALS News Today with a PhD in biochemistry. He covers the latest news and information on a variety of amyotrophic lateral sclerosis topics.| ALS News Today
Elevated blood and urine levels of metals like copper, selenium, and zinc raised disease risk by 3 times, and shortened patients' lives.| ALS News Today
Category archive page for News.| ALS News Today
PrimeC led to improvements in iron accumulation in people with amyotrophic lateral sclerosis (ALS) in a clinical trial, new data showed.| ALS News Today
The risk of death was nearly 60% lower in ALS patients given the experimental oral therapy CNM-Au8 than for an external placebo group, data show.| ALS News Today